ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,597Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 680

$665K Total Retail Price of All Prescriptions

Rank: 176 out of 680

346 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,905 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 588 554 1 2
SIMVASTATIN 505 481 2 3
LISINOPRIL 304 301 3 5
GABAPENTIN 257 240 4 15
POTASSIUM CHLORIDE 257 216 4 14
AMLODIPINE BESYLATE 257 250 4 1
METOPROLOL SUCCINATE 210 210 7 13
METOPROLOL TARTRATE 206 206 8 12
METFORMIN HCL 200 177 9 8
NAMENDA 170 170 10 35
CRESTOR 170 167 10 25
HYDROCHLOROTHIAZIDE 159 155 12 9
BUMETANIDE 154 139 13 102
LOSARTAN POTASSIUM 152 143 14 21
OMEPRAZOLE 151 144 15 7
CYMBALTA 147 135 16 46
PRAVASTATIN SODIUM 133 128 17 10
DONEPEZIL HCL 132 132 18 27
PANTOPRAZOLE SODIUM 126 126 19 30
SERTRALINE HCL 124 109 20 28
HYDROCODONE-ACETAMINOPHEN 117 114 S3 21 4
FUROSEMIDE 115 105 22 6
BYSTOLIC 114 113 23 79
TRAMADOL HCL 108 106 24 18
DIGOXIN 108 97 24 58
GLIMEPIRIDE 106 106 26 29
CITALOPRAM HBR 100 76 27 22
DIOVAN 99 99 28 31
CLOPIDOGREL 97 90 29 26
ISOSORBIDE MONONITRATE ER 96 96 30 59
TAMSULOSIN HCL 94 90 31 34
ZOLPIDEM TARTRATE 89 84 32 17
ATORVASTATIN CALCIUM 87 67 33 11
WARFARIN SODIUM 84 84 34 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 79 35 37
EXFORGE 77 70 36 151
CLONIDINE HCL 76 67 37 36
SPIRIVA 75 75 38 70
PRADAXA 73 73 39 255
FLUTICASONE PROPIONATE 69 67 40 41
SPIRONOLACTONE 68 63 41 82
ATENOLOL 66 62 42 19
CARBIDOPA-LEVODOPA 64 64 43 117
ALENDRONATE SODIUM 64 64 43 32
BUPROPION XL 63 42 45 161
PLAVIX 61 57 46 39
NEXIUM 60 51 47 16
METOLAZONE 60 58 47 201
TRIAMTERENE-HCTZ 59 55 49 52
KLOR-CON M20 59 58 49 61
SYNTHROID 58 58 51 38
COUMADIN 58 58 51 237
MELOXICAM 56 53 53 24
CARVEDILOL 55 37 54 23
ESCITALOPRAM OXALATE 55 55 54 45
CIPROFLOXACIN HCL 53 48 56 57
ALLOPURINOL 52 46 57 33
PROPAFENONE HCL 52 52 57 389
SINGULAIR 52 52 57 91
PRAMIPEXOLE DIHYDROCHLORIDE 52 51 57 204
TRAZODONE HCL 51 44 61 48
LOSARTAN-HYDROCHLOROTHIAZIDE 50 46 62 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.